Guidelines converge on patient selection and dosage for PSMA-RLT, suggesting increased treatment efficacy.
International guidelines largely converge on patient selection, dosing, and multidisciplinary implementation of PSMA-RLT. Ongoing trials including PSMAfore, PSMAddition, UpFrontPSMA, ENZA-p, and LuTectomy are expected to further define its role in earlier and combination treatment settings.
No takes yet. Share an insight, caveat, or question.
Al‐Khanaty et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: